Clinical Trial Update: The Bioavailability of Rifampicin in (FDCs) Widely Used in South Africa to Treat Drug-susceptible (TB) [Phase 1]

View source ↗

Summary

Phase 1 study reporting the bioavailability of rifampicin in fixed-dose combinations widely used in South Africa for drug-susceptible tuberculosis. The trial ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Rifampicin

Snippet

Sponsor: University of Cape Town | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED